XML 122 R94.htm IDEA: XBRL DOCUMENT v3.21.1
Carrying Amounts and Fair Value of Financial Instruments (Narrative) (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Fair Value Disclosures [Abstract]      
Investor funding period 30 days    
Review period to request a new third party appraisal 24 months    
Impaired financing receivable, recorded investment $ 2,219,330 $ 3,229,883 $ 9,364,125
Impaired Financing Receivable, Average Recorded Investment 3,864,751 $ 6,394,612 $ 11,026,748
Liabilities, fair value disclosure, recurring 0    
Fair value disclosure, off-balance sheet risks, amount, liability $ 143,600,000